GlaxoSmithKline GmbH & Co. KG


    • Company type:
      • Manufacturer
      • Research & Development
    • Year founded:
    • 2001
    • Employees (at the site):
    • 370
    • Turnover range:
    • >=125m EUR
    • Products/services:
    • Intestinal Diseases; Dermatology; Oncology; Research, Production and Distribution of Drugs; Immunology; Respiratory Tract Medication; Antibiotics; Vaccination and Immunotherapy; CNS; Allergy; Anaesthesia; Cardiology; Vaccine Development; Metabolic Diseases

    • Core competencies:
    • GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.
      GSK's mission is to improve the quality of human life by enabling people to do more, feel better and live longer.
      Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.
      GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products.

    • Language skills:
    • English
    • Key Tech / section:
      • Biotechnology: Prophylactic drug development
      • Biotechnology: Therapeutic drug development
    • Industries NACE:
      • 21: Manufacture of basic pharmaceutical products and pharmaceutical preparations
      • 72: Scientific research and development
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Dr. Sang-Jin Pak (Mrs.)
      - Management

      Adrian Bauer (Mr.)
      - Management